Heng Li

State Key Laboratory Of Experimental Hematology, CAMS And PUMC
Tianjin, 300020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Efficacy of Rituximab for Patients with Chronic Lymphocytic Leukemia.

Efficacy of Rituximab for Patients with Chronic Lymphocytic Leukemia.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: January 18, 2018

Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.

Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.

Journal: Oncotarget

Published: June 30, 2017

Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders.

Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders.

Journal: Oncotarget

Published: June 26, 2017

Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China.

Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: May 25, 2017

Analysis of Clinical Characteristics for 24 Cases of Nodal Marginal Zone Lymphoma.

Analysis of Clinical Characteristics for 24 Cases of Nodal Marginal Zone Lymphoma.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: May 10, 2017

The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.

The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.

Journal: International journal of hematology

Published: January 19, 2017

Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.

Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.

Journal: Chinese medical journal

Published: January 17, 2017

Divergence Analysis of Hepatitis Virus Infection between Aggressive and Indolent B Cell Non-Hodgkin's Lymphoma

Divergence Analysis of Hepatitis Virus Infection between Aggressive and Indolent B Cell Non-Hodgkin's Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 28, 2016

Curative effect analysis of rituximab combined with intensive chemotherapy for follicular lymphoma patients with bone marrow involvement

Curative effect analysis of rituximab combined with intensive chemotherapy for follicular lymphoma patients with bone marrow involvement

Journal: Zhonghua yi xue za zhi

Published: January 28, 2016

Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia.

Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: January 11, 2016

Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients

Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: August 26, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026